Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter - PubMed (original) (raw)
Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter
H H Sitte et al. J Neurochem. 1998 Sep.
Free article
Abstract
Amphetamine and related substances induce dopamine release. According to a traditional explanation, this dopamine release occurs in exchange for amphetamine by means of the dopamine transporter (DAT). We tested this hypothesis in human embryonic kidney 293 cells stably transfected with the human DAT by measuring the uptake of dopamine, tyramine, and D- and L-amphetamine as well as substrate-induced release of preloaded N-methyl-4-[3H]phenylpyridinium ([3H]MPP+). The uptake of substrates was sodium-dependent and was inhibited by ouabain and cocaine, which also prevented substrate-induced release of MPP+. Patch-clamp recordings revealed that all four substrates elicited voltage-dependent inward currents (on top of constitutive leak currents) that were prevented by cocaine. Whereas individual substrates had similar affinities in release, uptake, and patch-clamp experiments, maximal effects displayed remarkable differences. Hence, maximal effects in release and current induction were approximately 25% higher for D-amphetamine as compared with the other substrates. By contrast, dopamine was the most efficacious substrate in uptake experiments, with its maximal initial uptake rate exceeding those of amphetamine and tyramine by factors of 20 and 4, respectively. Our experiments indicate a poor correlation between substrate-induced release and the transport of substrates, whereas the ability of substrates to induce currents correlates well with their releasing action.
Similar articles
- [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A. Johnson RA, et al. Synapse. 1998 Sep;30(1):97-106. doi: 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M. Synapse. 1998. PMID: 9704886 - Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME, Khoshbouei H, Berg KA, Javitch JA, Clarke WP, Zhang M, Galli A. Gnegy ME, et al. Mol Pharmacol. 2004 Jul;66(1):137-43. doi: 10.1124/mol.66.1.137. Mol Pharmacol. 2004. PMID: 15213305 - Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
Kahlig KM, Galli A. Kahlig KM, et al. Eur J Pharmacol. 2003 Oct 31;479(1-3):153-8. doi: 10.1016/j.ejphar.2003.08.065. Eur J Pharmacol. 2003. PMID: 14612146 Review. - Knockout mice and dirty drugs. Drug addiction.
Uhl GR, Vandenbergh DJ, Miner LL. Uhl GR, et al. Curr Biol. 1996 Aug 1;6(8):935-6. doi: 10.1016/s0960-9822(02)00630-9. Curr Biol. 1996. PMID: 8805320 Review.
Cited by
- Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.
Minzenberg MJ. Minzenberg MJ. Neurotherapeutics. 2012 Jul;9(3):610-21. doi: 10.1007/s13311-012-0128-7. Neurotherapeutics. 2012. PMID: 22718077 Free PMC article. Review. - Tyramine excites rat subthalamic neurons in vitro by a dopamine-dependent mechanism.
Zhu ZT, Munhall AC, Johnson SW. Zhu ZT, et al. Neuropharmacology. 2007 Mar;52(4):1169-78. doi: 10.1016/j.neuropharm.2006.12.005. Epub 2006 Dec 28. Neuropharmacology. 2007. PMID: 17291545 Free PMC article. - Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers.
Joyce BM, Glaser PE, Gerhardt GA. Joyce BM, et al. Psychopharmacology (Berl). 2007 Apr;191(3):669-77. doi: 10.1007/s00213-006-0550-9. Epub 2006 Oct 10. Psychopharmacology (Berl). 2007. PMID: 17031708 - The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates.
Saha K, Li Y, Holy M, Lehner KR, Bukhari MO, Partilla JS, Sandtner W, Sitte HH, Baumann MH. Saha K, et al. Psychopharmacology (Berl). 2019 Mar;236(3):953-962. doi: 10.1007/s00213-018-5075-5. Epub 2018 Oct 22. Psychopharmacology (Berl). 2019. PMID: 30345459 Free PMC article. - Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
Akanuma SI, Yamazaki Y, Kubo Y, Hosoya KI. Akanuma SI, et al. Fluids Barriers CNS. 2018 Jan 8;15(1):1. doi: 10.1186/s12987-017-0087-9. Fluids Barriers CNS. 2018. PMID: 29307307 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources